Fiche centre
GSK Investigational Site
Milan — Italy
Essais liés3clinical trials
VilleMilanlocalisation
PaysItalylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06411249
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| GSK4527226 | Alzheimer | Phase 2 | NCT06079190 | PROGRESS-AD — Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease | TERMINATED |
| Belimumab (GSK1550188) | Lupus | Phase 4 | NCT06411249 | A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) | ACTIVE_NOT_RECRUITING |
| Belimumab | Myasthénie | Phase 2 | NCT01480596 | The Evaluation of Belimumab in Myasthenia Gravis (MG) | COMPLETED |